3.1. Abstract
INTRODUCTION: Mesenchymal stem cells (MSCs) provide an excellent source of pluripotent progenitor cells for tissue-engineering applications due to their proliferation capacity and differentiation potential. Genetic modification of MSCs with genes encoding tissue-specific growth factors and cytokines can induce and maintain lineagespecific differentiation. Due to anatomical and physiological similarities to humans, porcine research models have been proven valuable for the preclinical testing of tissue engineering protocols in large animals. The aim of this study was to evaluate optimized viral and non-viral ex vivo gene delivery systems with respect to gene transfer efficiency, maintenance of transgene expression, and safety issues using primary porcine MSCs as target cells.
MATERIALS AND METHODS: MSCs were purified from bone marrow aspirates from the proximal tibiae of four 3-month-old Danish landrace pigs by Ficoll step gradient separation and polystyrene adherence technique. Vectors expressing enhanced green fluorescent protein (eGFP) and human bone morphogenetic protein-2 (BMP-2) were transferred to the cells by different non-viral methods and by use of recombinant adenoassociated virus (rAAV)-mediated and retroviral gene delivery. Each method for gene delivery was optimized. Gene transfer efficiency was compared on the basis of eGFP expression as assessed by fluorescence microscopy and fluorescence-activated flow cytometry. BMP-2 gene expression and osteogenic differentiation were evaluated by realtime quantitative RT-PCR and histochemical detection of alkaline phosphatase activity, respectively.
RESULTS: Non-viral gene delivery methods resulted in transient eGFP expression by less than 2% of the cells. Using high titer rAAV-based vector up to 90% of the cells were transiently transduced. The efficiency of rAAV-mediated gene delivery was proportional to the rAAV vector titer applied. Retroviral gene delivery resulted in longterm transgene expression of porcine MSCs. A 26-fold increase in percentage of eGFP expressing cells (1.7% ±0.2% versus 44.1% ±5.0%, mean ±SD) and a 68-fold increa mean fluorescence intensity (327.4 ±56.6 versus 4.8 ±1.3) was observed by centrifugati of retroviral particles onto the target cell layer. Porcine MSCs that were BMP-2 transduced by optimized retroviral gene delivery demonstrated a significant increase in BMP-2 gene expression and showed increased osteogenic differentiation. Retrovirally transduced porcine MSCs were furthermore tested free of replication-competent viruses.
DISCUSSION: The non-viral gene transfer methods applied were significantly less efficient compared to the viral methods tested. However, due to advantages with respect to safety issues and ease of handling, improvement of non-viral gene delivery to primary MSCs deserves further attention. The high efficiency of rAAV-mediated gene delivery observed at high titers can be explained by the ability of rAAV vector to transduce nondividing cells and by its tropism towards porcine MSCs. rAAV-mediated gene delivery resulted in transient transgene expression due to lack of stable AAV genome integration. MLV-mediated retroviral gene delivery can be considered a safe method for long-term transgene expression by porcine MSCs, and is therefore particularly attractive for advanced tissue engineering strategies requiring extended transgene expression.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
3.8. References
S.E. Haynesworth, J. Goshima, V.M. Goldberg, and A.I. Caplan, Characterization of cells with osteogenic potential from human marrow, Bone 13(1), 81–88 (1992).
M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig, and D.R. Marshak, Multilineage potential of adult human mesenchymal stem cells, Science 284(5411), 143–147 (1999).
H.A. Awad, D.L. Butler, G.P. Boivin, F.N. Smith, P. Malaviya, B. Huibregtse, and A.I. Caplan, Autologous mesenchymal stem cell-mediated repair of tendon, Tissue Eng. 5(3), 267–277 (1999).
G. Ferrari, G. Cusella-De Angelis, M. Coletta, E. Paolucci, A. Stornaiuolo, G. Cossu, and F. Mavilio, Muscle regeneration by bone marrow-derived myogenic progenitors, Science 279(5356), 1528–1530 (1998).
P. Bianco and P.G. Robey, Stem cells in tissue engineering, Nature 414(6859), 118–121 (2001).
F. Gori, T. Thomas, K.C. Hicok, T.C. Spelsberg, and B.L. Riggs, Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation, J. Bone Miner. Res. 14(9), 1522–1535 (1999).
A.I. Caplan, Mesenchymal stem cells and gene therapy, Clin. Orthop. 379, S67–S70 (2000).
K.W. Culver and R.M. Blaese, Gene therapy for cancer, Trends Genet. 10(5), 174–178 (1994).
V. Cottard, D. Mulleman, P. Bouille, M. Mezzina, M.C. Boissier, and N. Bessis, Adeno-associated virusmediated delivery of IL-4 prevents collagen-induced arthritis, Gene Ther. 7(22), 1930–1939 (2000).
K.R. Clark, T.J. Sferra, and P.R. Johnson, Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle, Hum. Gene Ther. 8(6), 659–669 (1997).
D. Duan, P. Sharma, J. Yang, Y. Yue, L. Dudus, Y. Zhang, K.J. Fisher, and J.F. Engelhardt, Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue, J. Virol. 72(11), 8568–8577 (1998).
M.G. Kaplitt, P. Leone, R.J. Samulski, X. Xiao, D.W. Pfaff, K.L. O’Malley, and M.J. During, Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain, Nat. Genet. 8(2), 148–154 (1994).
T. Ikeda, T. Kubo, Y. Arai, T. Nakanishi, K. Kobayashi, K. Takahashi, J. Imanishi, M. Takigawa, and Y. Hirasawa, Adenovirus mediated gene delivery to the joints of guinea pigs, J. Rheumatol. 25(9), 1666–1673 (1998).
A.M. Douar, K. Poulard, D. Stockholm, and O. Danos, Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation, J. Virol. 75(4), 1824–1833 (2001).
J. Goater, R. Muller, G. Kollias, G.S. Firestein, I. Sanz, R.J. O’Keefe, and E.M. Schwarz, Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis, J. Rheumatol. 27(4): 983–989 (2000).
X. Xiao, J. Li, and R.J. Samulski, Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus, J. Virol. 72(3), 2224–2232 (1998).
F. S. Pedersen and M. Duch, Retroviruses in human gene therapy, Encyclopedia of Life Sciences (2003); http://els.wiley.com.
M. Ulrich-Vinther, M.D. Maloney, J.J. Goater, K. Soballe, M.B. Goldring, R.J. O’Keefe, and E.M. Schwarz, Light-activated gene transduction enhances adeno-associated virus vector-mediated gene expression in human articular chondrocytes, Arthritis Rheum. 46(8), 2095–2104 (2002).
D. Klein, S. Indraccolo, K. von Rombs, A. Amadori, B. Salmons, and W.H. Gunzburg, Rapid identification of viable retrovirus-transduced cells using the green fluorescent protein as a marker, Gene Ther. 4(11), 1256–1260 (1997).
H. Kotani, P.B. Newton 3rd, S. Zhang, Y.L. Chiang, E. Otto, L. Weaver, R.M. Blaese, W.F. Anderson, and G.J. McGarrity, Improved methods of retroviral vector transduction and production for gene therapy, Hum. Gene Ther. 5(1), 19–28 (1994).
K.A. Partridge and R.O. Oreffo, Gene delivery in bone tissue engineering: progress and prospects using viral and nonviral strategies, Tissue Eng. 10(1–2), 295–307 (2004).
A.M. Douar, K. Poulard, D. Stockholm, and O. Danos, Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation, J Virol 75(4):1824–1833 (2001).
G. Seisenberger, M.U. Ried, T. Endress, H. Buning, M. Hallek, and C. Brauchle, Real-time singlemolecule imaging of the infection pathway of an adeno-associated virus.” Science 2001.Nov.30.;294.(5548.):1929.–32. 294,(November 2001):1929–32.
T.R. Flotte, S.A. Afione, and P.L. Zeitlin, Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration, Am. J. Respir. Cell Mol. Biol. 11(5), 517–521 (1994).
G. Seisenberger, M.U. Ried, T. Endress, H. Buning, M. Hallek, and C. Brauchle, Real-time singlemolecule imaging of the infection pathway of an adeno-associated virus, Science 294(5548), 1929–1932 (2001).
K.J. Fisher, G.P. Gao, M.D. Weitzman, R. DeMatteo, J.F. Burda, and J.M. Wilson, Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis, J. Virol. 70(1), 520–532 (1996).
J.D. Mosca, J.K. Hendricks, D. Buyaner, J. Davis-Sproul, L.C. Chuang, M.K. Majumdar, R. Chopra, F. Barry, M. Murphy, M.A. Thiede, U. Junker, R.J. Rigg, S.P. Forestell, E. Bohnlein, R. Storb, and B.M. Sandmaier, Mesenchymal stem cells as vehicles for gene delivery, Clin. Orthop. 379, S71–S90 (2000).
S. Hacein-Bey-Abina, C. von Kalle, M. Schmidt, M.P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C.S. Osborne, R. Pawliuk, E. Morillon, R. Sorensen, A. Forster, P. Fraser, J.I. Cohen, B.G. de Saint, I. Alexander, U. Wintergerst, T. Frebourg, A. Aurias, D. Stoppa-Lyonnet, S. Romana, I. Radford-Weiss, F. Gross, F. Valensi, E. Delabesse, E. Macintyre, F. Sigaux, J. Soulier, L.E. Leiva, M. issler, C. Prinz, T.H. Rabbitts, F. Le Deist, A. Fischer, and M. Cavazzana-Calvo, LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1, Science 302(5644), 415–419 (2003).
H.P. Kiem, S. Sellers, B. Thomasson, J.C. Morris, J.F. Tisdale, P.A. Horn, P. Hematti, R. Adler, K. Kuramoto, B. Calmels, A. Bonifacino, J. Hu, C. von Kalle, M. Schmidt, B. Sorrentino, A. Nienhuis, C.A. Blau, R.G. Andrews, R.E. Donahue, and C.E. Dunbar, Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia, Mol. Ther. 9(3), 389–395 (2004).
M. Duch, K. Paludan, J. Lovmand, M.S. Sorensen, P. Jorgensen, and F.S. Pedersen, The effect of selection for high-level vector expression on the genetic and functional stability of a single transcript vector derived from a low-leukemogenic murine retrovirus, Hum. Gene Ther. 6(3), 289–296 (1995).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this paper
Cite this paper
Stiehler, M. et al. (2006). Optimizing Viral and Non-Viral Gene Transfer Methods for Genetic Modification of Porcine Mesenchymal Stem Cells. In: Fisher, J.P. (eds) Tissue Engineering. Advances in Experimental Medicine and Biology, vol 585. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-34133-0_3
Download citation
DOI: https://doi.org/10.1007/978-0-387-34133-0_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-32664-1
Online ISBN: 978-0-387-34133-0
eBook Packages: EngineeringEngineering (R0)